Brett Matthew Hall - 03 Aug 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role: Chief Scientific Officer
Signature: By: /s/ Michael D. Bookman, Attorney-in-Fact for Brett M. Hall
Issuer symbol: IMRX
Transactions as of: 03 Aug 2021
Net transactions value: +$20,295
Form type: 4
Filing time: 04 Aug 2021, 06:05:34 UTC
Previous filing: 29 Jul 2021
Next filing: 22 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMRX	Class A Common Stock	Conversion of derivative security		+5,040			5,040	03 Aug 2021	Direct	F1
transaction	IMRX	Class A Common Stock	Purchase	$20,295	+1,353	+27%	$15.00	6,393	03 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMRX	Series A Preferred Stock	Conversion of derivative security		-1,636	-100%		0	03 Aug 2021	Class A Common Stock	1,636		Direct	F1
transaction	IMRX	Series B Preferred Stock	Conversion of derivative security		-3,404	-100%		0	03 Aug 2021	Class A Common Stock	3,404		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.